When looking into more detail to detection of individual lesions, this study shows that the sensitivity and specificity of FDG PET for lesion detection (pre-operatively) was 94.3% and 48.8% (group A)/83.6% and 20.5% (group B), respectively in patients with grade 1–2, ER+ BC. The gene discussed is ESR1; the disease is breast cancer.